lopinavir has been researched along with Leukemia, Myeloid, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Azzari, C; Bortone, B; Casini, T; Favre, C; Galli, L; Moriondo, M; Pegoraro, F; Sieni, E; Tondo, A | 1 |
| Algarra Algarra, JL; Amutio Diez, ME; Arnan Sangerman, M; Bergua Burgues, JM; Bernal Del Castillo, T; Botella Prieto, C; Cano, I; Cervera Calvo, M; Cervero, C; Contento Gonzalo, A; Cornago Navascués, J; Cuello García, R; Cuevas Palomares, L; de Cabo López, E; de Laiglesiai, A; De Miguel Llorente, D; Escolano Escobar, C; Figuera Álvarez, Á; Foncillas, MÁ; Franco Villegas, AC; García Boyero, R; Hermosín Ramos, L; Herrera, P; López Lorenzo, JL; Martínez, P; Martínez-López, J; Mateos Rodríguez, MC; Megías-Vericat, JE; Montesinos, P; Najera Irazu, MJ; Navas Elorza, B; Olave, MT; Palanques-Pastor, T; Piñana, JL; Rodriguez Macias, G; Roldán Pérez, A; Sanz, MÁ; Seri Merino, C; Serrano, J; Sobas, M; Vidriales Vicente, MB; Villafuerte Gutiérrez, P; Vives, S | 1 |
| Bader, J; Driessen, C; Kraus, M; Müller-Ide, H; Overkleeft, H; Rückrich, T | 1 |
3 other study(ies) available for lopinavir and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression.
Topics: Antineoplastic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Immune Tolerance; Infant; Leukemia, Myeloid, Acute; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
Topics: Adult; COVID-19; Humans; Leukemia, Myeloid, Acute; Lopinavir; Risk Factors; SARS-CoV-2 | 2021 |
Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
Topics: Apoptosis; Cytotoxins; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Leukemic; HIV Protease Inhibitors; Humans; Leukemia, Myeloid, Acute; Lopinavir; Nelfinavir; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-akt; Ritonavir; Saquinavir; Signal Transduction; Tumor Cells, Cultured | 2014 |